Ocular Therapeutix (OCUL) Other Non Operating Income (2013 - 2026)
Ocular Therapeutix's quarterly Other Non Operating Income came in at $1.8 million in Q1 2026, up 402.31% year-on-year from $364714.8 in Q1 2025, and up 4.99% quarter-over-quarter from $1.7 million in Q4 2025.
Ocular Therapeutix has reported Other Non Operating Income for 13 years, with the latest figure at $1.8 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 402.31% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (down 45.82% YoY), and the FY2025 full-year result was $29000.0, up 100.1% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $1.8 million, up from $1.7 million in the prior quarter.
- The five-year high for Other Non Operating Income was $14.2 million in Q3 2023, with the low at -$28.0 million in Q1 2024.
- Average Other Non Operating Income over 5 years is -$1.1 million, with a median of -$1000.0 recorded in 2023.
- Year-over-year, Other Non Operating Income jumped 1418900.0% in 2023 and tumbled 2794900.0% in 2024.
- Tracing OCUL's Other Non Operating Income over 5 years: stood at $1000.0 in 2022, then slumped by 1419200.0% to -$14.2 million in 2023, then jumped by 153.65% to $7.6 million in 2024, then plunged by 77.08% to $1.7 million in 2025, then advanced by 4.99% to $1.8 million in 2026.
- The last three Other Non Operating Income figures came in at $1.8 million (Q1 2026), $1.7 million (Q4 2025), and -$938000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.83 Mn |
| Dec 31, 2025 | 1.75 Mn |
| Sep 30, 2025 | -938,000.00 |
| Jun 30, 2025 | -172,000.00 |
| Mar 31, 2025 | -606,000.00 |
| Sep 30, 2024 | 7.61 Mn |
| Jun 30, 2024 | -2.45 Mn |
| Mar 31, 2024 | -27.95 Mn |
| Dec 31, 2023 | -14.19 Mn |
| Sep 30, 2023 | 14.19 Mn |
| Jun 30, 2023 | 1.13 Mn |
| Mar 31, 2023 | -1,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 2.77 Mn |
| Mar 31, 2022 | -2,000.00 |
| Dec 31, 2021 | -62.25 Mn |
| Sep 30, 2021 | 23.84 Mn |
| Jun 30, 2021 | 13.40 Mn |
| Mar 31, 2021 | 25.02 Mn |
| Dec 31, 2020 | -69.55 Mn |
| Sep 30, 2020 | 3.77 Mn |
| Jun 30, 2020 | -17.01 Mn |
| Mar 31, 2020 | -3.40 Mn |
| Dec 31, 2019 | -3.02 Mn |
| Sep 30, 2019 | 5.72 Mn |
| Jun 30, 2019 | -1.61 Mn |
| Mar 31, 2019 | 3.22 Mn |
| Sep 30, 2017 | 5,000.00 |
| Sep 30, 2016 | -1,000.00 |
| Dec 31, 2015 | 1,000.00 |
| Sep 30, 2015 | 3,000.00 |
| Jun 30, 2015 | 3,000.00 |
| Sep 30, 2014 | -111,000.00 |
| Jun 30, 2014 | -190,000.00 |
| Mar 31, 2014 | -141,000.00 |
| Dec 31, 2013 | 3,000.00 |
| Sep 30, 2013 | 4,000.00 |
| Jun 30, 2013 | 3,000.00 |